婦科內分泌學熱點聚焦（簡體書）

536. Rabe T，Runnebaum B，Weicker H.Kohlenhydrat—undAndrogenstoffwechsel unter oraler Kontrazeption mit einernorethisteronhaltigen Dreiphasenpille(TriNovumR).In:Runnebaum B，Rabe T(Hrsg).Hormonale Kontrazeption. Steinkopff—Verlag， Darmstadt， 1985: 40—57
537. Rabe T， Runnebaum B， Kaiser E， et al.Metabolic effectsof a norgestimate containing low—dose pill(Cilest 250/35) on lipid and carbohydrate metabolism and blood clotting.In: Genazzani AR， Volpe A，Faccinetti F.Selected free communicationsat the First Internation Congress of GynecologicalEndocrinology.Parthenon Publishing Group，1987:443—449
538. Rabe T，Runnebaum B，Unger R，et al.Clinical and metabolic effects of two low dosecombined pills for oral contraception containing gestodene(SHD 356C) or levonorgestrel(MicrogynonR).GynecologicalEndocrinology.The Proceedings of the First International Congresson Gynecological Endocrinology.Genazzani AR，Volpe A，Facanetti F.Parthenon Publ.Group，1987:503—516
539. Rabe T.Familienplanung und Empfangnisverhutung beider Frau in Deutschland.In:Kreienberg R，Ludwig H(Hrsg).Werte Wissen Wandel.125 Jahre Deutsche Gesellschaft furGynakologie und Geburtshilfe.Berlin : Springer Verlag， 2010 : 555—585
540. Reape KZ，DiLiberti CE， Hendy CH，et al.Effects on serum hormone levels of low—dose estrogen in place of placebo during the hormone—free interval of an oral contraceptive.Contraception， 2008， 77:34—39
541. Redmond GP，Olson WH，Lippman JS，et al.Norgestimate and ethinyl estradiol in the treat—ment of acne vulgaris: a randomized， placebo—controlled trial.Obstet Gynecol，1997 ， 89 : 615—622
542. Reid RL，Yen SS.Premenstrual syndrome.Am J ObstetGynecol，1981，139:85—104
543. Reid RL，Westhoff C，Mansour D，et al.Oral Contraceptives and Venous Thromboembolism—Consensus Opinionfrom an International Workshop held in Berlin，Germany in December 2009.J Fam Plann Reprod Health Care，2010，36:117—122
544. Rice C，Killick S， Hickling D， et al.Ovarian activity and vaginal bleeding patterns with a desogestrelonlypreparation at three different doses.Hum Reprod，1996，11:737—740
545. Riman T，Dickman PW，Nilsson S，et al.Risk factors for epithelial borderline ovarian tumors:results of a Swedish casecontrol study.Gynecol Oncol，2001，83:575—585
546. Rimm E，Manson J，Stampfer M，et al.Oral contraceptive use and the risk of type 2 diabetes mellitus in a large prospective study of women.Diabetologia，1992，35 : 967—972
547. Rivera AD，Frank E.Late luteal phase dysphoric disorder in young women.Am J Psychiatry，1990，147:1634—1636
548. Rock J，Garcia CR，Pincus G.Synthetic progestins in the normal human menstrual cycle.Recent Prog Horm Res，1957，13:323—339
549. Rock J，Garcia CR.Observed effects of 19—nor steroids on ovulation and menstruation.In:Proceedings of a Symposiumon 19—Nor Progestational Steroids.Chicago， Searle ResearchLaboratories，1957:14—310.